SCHEMBL24525604

SCHEMBL24525604

C1COCCOCCOCCOC(CC2COCCOCCOCCO2)CN1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM3 P20309 1/20 0.39
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
ADRB2 P07550 1/20 0.32
HTR1A P08908 1/20 0.32
SLC6A2 P23975 1/20 0.32
HTR2A P28223 1/20 0.32
SLC6A4 P31645 1/20 0.32
ADRA1A P35348 1/20 0.32
HTR2B P41595 1/20 0.32
SLC6A3 Q01959 1/20 0.32
ADRA2C P18825 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL28834627 0.80 SLC6A2 (0.38) ADRB2HTR1ASLC6A2HTR2ASLC6A4
Ammonia Solution, Strong SCHEMBL27991104 0.80 SLC6A2 (0.38) ADRB2HTR1ASLC6A2HTR2ASLC6A4
SCHEMBL536771 0.80 SLC6A2 (0.42) ADRB2HTR1ASLC6A2HTR2ASLC6A4
SCHEMBL28117365 0.77 CHRM2 (0.52) CHRM2CHRM4CHRM5CHRM3
Methane SCHEMBL28101368 0.77 SLC6A2 (0.36) ADRB2HTR1ASLC6A2HTR2ASLC6A4
SCHEMBL19441534 0.77 MEN1 (0.48) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL27864779 0.76 SLC6A2 (0.36) ADRB2HTR1ASLC6A2HTR2ASLC6A4
SCHEMBL19441659 0.73 MEN1 (0.48) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL19441530 0.73 MEN1 (0.48) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL24103308 0.72 MEN1 (0.46) MEN1KMT2ACHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220193249-A1 Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-O-) Units In A Ring POLYTHERICS LIMITED (GB) 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193249-A1 Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-O-) Units In A Ring BCR, CD2BP2, LANCL1 MEN1 558/4885KMT2A 942/4885CHRM2 4467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.